Access

News

Nature 418, 5 (4 July 2002) | doi:10.1038/418005b

Biotech woes set to hit academics

Jonathan Knight

The scandals and stock-market woes that have left the biotechnology industry reeling this year are beginning to take their toll on campuses, according to early indicators.As biotech stocks collapse — collectively, they have lost two-thirds of their value in the past two years — companies may be shying away from funding research collaborations with academics.